Skip to Main Content

Paper Details

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
Lancet Haematology,The
56
2015
Eltrombopag, Haemorrhage, Patients, Platelet, acute myeloid leukaemia, advanced, advanced myelodysplastic syndromes, antileukaemic, bone, bone-marrow blast, bone-marrow blasts, chromosome 7, chromosome 7 abnormalities, decreased appetite, diarrhoea, eltrombopag, fatigue, myelodysplastic syndrome, nausea, patients, peripheral blasts, platelet, platelets, pneumonia, pyrexia, thrombocytopenia, thrombocytopenic, thrombopoietin receptor
Author NameAffiliation
Suman KambhampatiUniversity of Kansas Medical Center
  • 1 - 1

Datasets

Release 1.2